Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Change in Account Payables (2018 - 2025)

Dna X (SONM) has disclosed Change in Account Payables for 8 consecutive years, with -$175000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Account Payables fell 62.04% year-over-year to -$175000.0, compared with a TTM value of $11.4 million through Sep 2025, up 492.53%, and an annual FY2024 reading of $14.3 million, up 1218.76% over the prior year.
  • Change in Account Payables was -$175000.0 for Q3 2025 at Dna X, down from $3.3 million in the prior quarter.
  • Across five years, Change in Account Payables topped out at $13.8 million in Q4 2024 and bottomed at -$5.6 million in Q1 2025.
  • Average Change in Account Payables over 5 years is $1.2 million, with a median of $311000.0 recorded in 2023.
  • Peak annual rise in Change in Account Payables hit 3769.41% in 2025, while the deepest fall reached 1128.52% in 2025.
  • Year by year, Change in Account Payables stood at -$3.0 million in 2021, then soared by 386.74% to $8.7 million in 2022, then crashed by 139.22% to -$3.4 million in 2023, then surged by 504.58% to $13.8 million in 2024, then crashed by 101.27% to -$175000.0 in 2025.
  • Business Quant data shows Change in Account Payables for SONM at -$175000.0 in Q3 2025, $3.3 million in Q2 2025, and -$5.6 million in Q1 2025.